CO190 Clinical Outcomes of Semaglutide 2.4 Mg in Patients with Obesity or Overweight in a Real-World Setting: A 6-Month Retrospective Study in the United States

Autor: Ruseva, A., Fabricatore, A., Ó Hartaigh, B., Michalak, W., Zhao, Z.
Zdroj: In Value in Health June 2023 26(6) Supplement:S50-S51
Databáze: ScienceDirect